BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HIST1H3B, H3_1, P68431, H3FJ, H3/j, H3FF, H3/f, H3_f, H3FK, H3F1K, H3/k, H3FH, H3/h, H3FI, H3/i, H3FD, H3/d, H3FB, H3/b, H3FC, H3/c, H3FL, H3/l, H3FA, H3/A, ENSG00000124693, 8358
21 results:

  • 1. Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance.
    Palma FR; Coelho DR; Pulakanti K; Sakiyama MJ; Huang Y; Ogata FT; Danes JM; Meyer A; Furdui CM; Spitz DR; Gomes AP; Gantner BN; Rao S; Backman V; Bonini MG
    Cell Rep; 2024 Mar; 43(3):113897. PubMed ID: 38493478
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
    Zhang X; Guo H; Chen J; Xu C; Wang L; Ke Y; Gao Y; Zhang B; Zhu J
    Cancer Lett; 2023 Sep; 572():216355. PubMed ID: 37597651
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
    Hooper AT; Marquette K; Chang CB; Golas J; Jain S; Lam MH; Guffroy M; Leal M; Falahatpisheh H; Mathur D; Chen T; Kelleher K; Khandke K; Muszynska E; Loganzo F; Rosfjord E; Lucas J; Kan Z; Subramanyam C; O'Donnell C; Neri D; Gerber HP; May C; Sapra P
    Mol Cancer Ther; 2022 Sep; 21(9):1462-1472. PubMed ID: 35793468
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear pore protein NUP210 depletion suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response.
    Amin R; Shukla A; Zhu JJ; Kim S; Wang P; Tian SZ; Tran AD; Paul D; Cappell SD; Burkett S; Liu H; Lee MP; Kruhlak MJ; Dwyer JE; Simpson RM; Hager GL; Ruan Y; Hunter KW
    Nat Commun; 2021 Dec; 12(1):7216. PubMed ID: 34903738
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1.
    Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
    Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
    Hahm ER; Lee J; Abella T; Singh SV
    Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.
    Dufour C; Perbet R; Leblond P; Vasseur R; Stechly L; Pierache A; Reyns N; Touzet G; Le Rhun E; Vinchon M; Maurage CA; Escande F; Renaud F
    Brain Pathol; 2020 Jan; 30(1):179-190. PubMed ID: 31348837
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.
    Stenman A; Svahn F; Hojjat-Farsangi M; Zedenius J; Söderkvist P; Gimm O; Larsson C; Juhlin CC
    Am J Surg Pathol; 2019 Mar; 43(3):409-421. PubMed ID: 30451732
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. cancer incidence and all-cause mortality among civilian men and women employed by the Royal Norwegian Navy between 1950 and 2005.
    Strand LA; Martinsen JI; Rudvin I; Fadum EA; Borud EK
    Cancer Epidemiol; 2018 Dec; 57():1-6. PubMed ID: 30205311
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human breast cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression.
    do Nascimento-Neto LG; Cabral MG; Carneiro RF; Silva Z; Arruda FVS; Nagano CS; Fernandes AR; Sampaio AH; Teixeira EH; Videira PA
    Anticancer Agents Med Chem; 2018; 18(4):521-528. PubMed ID: 29141557
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.
    Lee YH; Martin-Orozco N; Zheng P; Li J; Zhang P; Tan H; Park HJ; Jeong M; Chang SH; Kim BS; Xiong W; Zang W; Guo L; Liu Y; Dong ZJ; Overwijk WW; Hwu P; Yi Q; Kwak L; Yang Z; Mak TW; Li W; Radvanyi LG; Ni L; Liu D; Dong C
    Cell Res; 2017 Aug; 27(8):1034-1045. PubMed ID: 28685773
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spectroscopic Photoacoustic Molecular Imaging of breast cancer using a B7-H3-targeted ICG Contrast Agent.
    Wilson KE; Bachawal SV; Abou-Elkacem L; Jensen K; Machtaler S; Tian L; Willmann JK
    Theranostics; 2017; 7(6):1463-1476. PubMed ID: 28529630
    [No Abstract]    [Full Text] [Related]  

  • 13. AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues.
    Juan G; Bush TL; Ma C; Manoukian R; Chung G; Hawkins JM; Zoog S; Kendall R; Radinsky R; Loberg R; Friberg G; Payton M
    J Transl Med; 2014 Nov; 12():307. PubMed ID: 25367255
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
    Maeda N; Yoshimura K; Yamamoto S; Kuramasu A; Inoue M; Suzuki N; Watanabe Y; Maeda Y; Kamei R; Tsunedomi R; Shindo Y; Inui M; Tamada K; Yoshino S; Hazama S; Oka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(Suppl 4):S546-54. PubMed ID: 24562936
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Small-molecule inhibitor BMS-777607 induces breast cancer cell polyploidy with increased resistance to cytotoxic chemotherapy agents.
    Sharma S; Zeng JY; Zhuang CM; Zhou YQ; Yao HP; Hu X; Zhang R; Wang MH
    Mol Cancer Ther; 2013 May; 12(5):725-36. PubMed ID: 23468529
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
    Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
    Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
    Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
    FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.
    Arigami T; Narita N; Mizuno R; Nguyen L; Ye X; Chung A; Giuliano AE; Hoon DS
    Ann Surg; 2010 Dec; 252(6):1044-51. PubMed ID: 21107115
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models.
    Hardwicke MA; Oleykowski CA; Plant R; Wang J; Liao Q; Moss K; Newlander K; Adams JL; Dhanak D; Yang J; Lai Z; Sutton D; Patrick D
    Mol Cancer Ther; 2009 Jul; 8(7):1808-17. PubMed ID: 19567821
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.
    Skaland I; Janssen EA; Gudlaugsson E; Klos J; Kjellevold KH; Søiland H; Baak JP
    Mod Pathol; 2007 Dec; 20(12):1307-15. PubMed ID: 17917671
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.